USF-LVHN SELECT

IMMUNE PROFILING AND CLINICAL OUTCOMES OF TIL THERAPYFOR HIGH-RISK BCG-EXPOSED NMIBC

Publication/Presentation Date

5-2025

Volume

213

Issue

5

First Page

e500

Last Page

e500

Department(s)

USF-LVHN SELECT Program, USF-LVHN SELECT Program Students

Document Type

Article

Share

COinS